Last10K.com

Davita Inc. (DVA) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2020

SEC Filings

DVA Quarterly Reports

Davita Inc.

CIK: 927066 Ticker: DVA


davitalogorgbfa62.jpg


Contact:        Jim Gustafson
Investor Relations                    
DaVita Inc.
(310) 536-2585
DaVita Inc. COVID-19 Response Efforts and 1st Quarter 2020 Results
Denver, Colorado, May 5, 2020 — During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its patients whose lives depend on receiving dialysis treatment multiple times each week.

During this time of great challenge, our top priorities continue to be the health, safety and well-being of our patients, teammates and physician partners and helping to ensure that our patients have the ability to maintain continuity of care throughout this crisis, whether in the inpatient, in-center or home setting. Throughout this crisis, we are working to support our communities and help preserve precious hospital resources. We have been collaborating with the U.S. Department of Health and Human Services, the Centers for Medicare and Medicaid Services, Centers for Disease Control and Prevention, and dialysis providers nationwide to help ensure that the dialysis community is able to support dialysis patients nationwide.

“I am proud and humbled by the amazing efforts of our 65,000 teammates around the world,” said Javier Rodriguez, CEO of DaVita Inc., “I offer my deepest gratitude to them all, especially to our caregiving teammates and physician partners working heroically to provide life-sustaining therapy to approximately 238,000 dialysis patients globally.”
In addition, the Company announced financial and operating results for the first quarter ended March 31, 2020.
Financial results for the quarter ended March 31, 2020
First quarter 2020 highlights:
Consolidated revenues of $2.841 billion.
Operating income of $465 million or 16.4% operating margin.
Diluted earnings per share from continuing operations of $1.81 and adjusted diluted earnings per share from continuing operations of $1.83.
Operating cash flow from continuing operations of $360 million and free cash flow from continuing operations of $184 million.
Repurchased 4,052,298 shares of our common stock at an average cost of $74.81 per share.

 
Three months ended
March 31,
 
2020
 
2019
Net income attributable to DaVita Inc.:
(dollars in millions, except per share data)
 
Net income from continuing operations
$
230

 
$
120

 
Diluted per share
$
1.81

 
$
0.72

 
Adjusted net income from continuing operations(1)
$
232

 
$
152

 
Diluted per share adjusted(1)
$
1.83

 
$
0.91

 
Net income
$
240

 
$
149

 
Diluted per share
$
1.89

 
$
0.90


1

The following information was filed by Davita Inc. (DVA) on Tuesday, May 5, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Davita Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Davita Inc..

Continue

Assess how Davita Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Davita Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Cash Flow
Expense
Income
Debt
Geography
Earnings
Product
Shares
Other
Inside Davita Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets (Unaudited)
Consolidated Balance Sheets (Unaudited) (Parenthetical)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Comprehensive Income (Unaudited)
Consolidated Statements Of Equity (Unaudited)
Consolidated Statements Of Income (Unaudited)
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income (Detail)
Accumulated Other Comprehensive (Loss) Income (Tables)
Acquisitions And Divestitures
Acquisitions And Divestitures (Tables)
Acquisitions And Divestitures - Additional Information (Detail)
Acquisitions And Divestitures - Aggregate Purchase Cost Allocations For Acquisitions (Detail)
Acquisitions And Divestitures Contingent Earn-Out Obligations (Details)
Changes In Davita Inc.'S Ownership Interest In Consolidated Subsidiaries
Changes In Davita Inc.'S Ownership Interest In Consolidated Subsidiaries (Tables)
Changes In Davita Inc.'S Ownership Interest In Consolidated Subsidiaries - Effects Of Changes In Davita Inc's Ownership Interest On Company's Equity (Detail)
Condensed Consolidated Interim Financial Statements Condensed Consolidaed Interim Financial Statements (Policies)
Condensed Consolidated Interim Financial Statements Condensed Consolidated Interim Financial Statements
Condensed Consolidating Financial Statements
Condensed Consolidating Financial Statements (Tables)
Condensed Consolidating Financial Statements - Condensed Consolidating Balance Sheets (Detail)
Condensed Consolidating Financial Statements - Condensed Consolidating Statements Of Cash Flows (Detail)
Condensed Consolidating Financial Statements - Condensed Consolidating Statements Of Comprehensive Income (Detail)
Condensed Consolidating Financial Statements - Condensed Consolidating Statements Of Operations (Detail)
Condensed Consolidating Financial Statements Additional Information (Details)
Contingencies
Contingencies - Additional Information (Detail)
Earnings Per Share (Notes)
Earnings Per Share Earnings Per Share (Tables)
Earnings Per Share Earnings Per Share - Reconciliation Of Numberators And Denominators Used To Calculate Basic And Diluted Earnings Per Share (Details)
Equity Method And Other Investments
Equity Method And Other Investments - Additional Information (Details)
Equity Method And Other Investments Equity Method And Other Investments (Details)
Equity Method And Other Investments Equity Method And Other Investments (Tables)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Tables)
Fair Value Of Financial Instruments - Assets, Liabilities And Temporary Equity Measured At Fair Value On Recurring Basis (Detail)
Fair Value Of Financial Instruments Fair Value Of Financial Instruments (Details)
Goodwill
Goodwill (Tables)
Goodwill - Changes In Goodwill By Reportable Segments (Detail)
Goodwill - Narrative (Details)
Held For Sale And Discontinued Operations (Tables)
Held For Sale And Discontinued Operations Additional Information (Details)
Held For Sale And Discontinued Operations Held For Sale And Discontinued Operations
Held For Sale And Discontinued Operations Schedule Of Cash Flows Of Discontinued Operations Related To Dmg (Details)
Held For Sale And Discontinued Operations Schedule Of Financial Results Of Dmg's Discontinued Operations (Details)
Income Taxes
Income Taxes - Additional Information (Detail)
Investments In Debt And Equity Securities
Investments In Debt And Equity Securities (Detail)
Investments In Debt And Equity Securities (Tables)
Investments In Debt And Equity Securities - Additional Information (Detail)
Leases Lease Expense Components (Details)
Leases Leases
Leases Leases (Tables)
Leases Leases - Additional Information (Details)
Leases Leases Other Information (Details)
Leases Schedule Of Minimum Lease Payments (Details)
Long-Term Debt
Long-Term Debt (Detail)
Long-Term Debt (Tables)
Long-Term Debt - Additional Information (Detail)
Long-Term Debt - Effects Of Interest Rate Swap And Cap Agreements (Detail)
Long-Term Debt - Scheduled Maturities Of Long-Term Debt (Detail)
Long-Term Debt Schedule Of Derivative Instruments (Details)
Long-Term Incentive Compensation
Long-Term Incentive Compensation - Additional Information (Detail)
New Accounting Standards
Other Commitments
Other Commitments - Additional Information (Detail)
Revenue Recognition Revenue Recognition
Revenue Recognition Revenue Recognition (Detail)
Revenue Recognition Segment Revenue By Major Payor (Tables)
Revenue Recognition Segment Revenue By Payor (Details)
Segment Reporting
Segment Reporting (Tables)
Segment Reporting - Summary Of Assets By Segment (Detail)
Segment Reporting - Summary Of Assets By Segment (Phantom) (Detail)
Segment Reporting - Summary Of Depreciation And Amortization Expense By Segment (Detail)
Segment Reporting - Summary Of Expenditures For Property And Equipment By Segment (Detail)
Segment Reporting - Summary Of Segment Net Revenues, Segment Operating Income (Loss) And Reconciliation Of Segment Income To Consolidated Income Before Income Taxes (Detail)
Segment Reporting Segment Reporting - Additional Information (Details)
Share Repurchases
Share Repurchases (Details)
Share Repurchases Share Repurchase Tender Offer (Details)
Share Repurchases Share Repurchases (Tables)
Subsequent Events (Notes)
Subsequent Events Additional Information (Details)
Variable Interest Entities
Variable Interest Entities - Additional Information (Detail)
Ticker: DVA
CIK: 927066
Form Type: 10-Q Quarterly Report
Accession Number: 0000927066-20-000073
Submitted to the SEC: Tue May 05 2020 5:10:23 PM EST
Accepted by the SEC: Tue May 05 2020
Period: Tuesday, March 31, 2020
Industry: Health And Allied

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/dva/0000927066-20-000073.htm